Recent Advances in CRISPR/Cas9-Based Genome Editing Tools for Cardiac Diseases

Abstract excerpt

In the past two decades, genome editing has proven its value as a powerful tool for modeling or even treating numerous diseases. After the development of protein-guided systems such as zinc finger nucleases (ZFNs) and transcription activator-like effector nucleases (TALENs), which for the first time made DNA editing an actual possibility, the advent of RNA-guided techniques has brought about an epochal change....

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to CRISPR and Genetic Engineering
• Share to RNA and protein synthesis mechanisms
• Share to Viral Infections and Immunology Research